The DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias
Abstract
The knowledge regarding putative inflammatory component(s) participating in Alzheimer's disease (AD) and vascular dementia (VAD) is scarce. Recently, we have demonstrated the presence of certain inflammatory cytokines in the cerebrospinal fluid (CSF) of demented patients. Although the initial event(s) triggering the neurodegenerative processes in AD versus VAD may be different and lead to different neuropathological changes, it may initiate a similar cascade of cytokine production in response to neuronal injury. The cytokines released in the central nervous system (CNS) may, in turn, act in a similar manner in both diseases, amplifying some pathological changes such as amyloidogenesis and white matter lesions or on the contrary acting as neuroprotective molecules. This review will focus on the intracerebral production of the pro- and anti-inflammatory cytokines interleukin IL-1beta, IL-1 receptor antagonist (IL-1ra), IL-6 and TNF-alpha in dementia, and their relation to gene polymorphism, to cerebral neuronal damage, apoptosis, and to clinical variables of dementia. Our results, which show for the first time strikingly increased CSF levels of TNF-alpha but not of TNF-beta, IL-1beta or IL-6 in AD and VAD, may form a conceptual framework for further studies of neuroprotective mechanisms in dementias.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as well as in AD patients’ CSF and serum [215,216,217,218,219,220,221,222]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [220]
Citations
Cites
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,899
Wilson, A. G., Symons, J. A., McDowell, T. L., McDevitt, H. O., & Duff, G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3195 · Cited by 2,218
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Martinou, J.-C., Dubois-Dauphin, M., Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D., Catsicas, S., & Pietra, C. (1994) · Neuron · doi:10.1016/0896-6273(94)90266-6 · Cited by 1,087
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7951 · Cited by 1,030
The −308 tumor necrosis factor-α promoter polymorphism effects transcription
Kroeger, K. M., Carville, K. S., & Abraham, L. J. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00052-7 · Cited by 864
A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
Itoh, N., & Nagata, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82075-0 · Cited by 839
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Lieberman, A. P., Pitha, P. M., Shin, H. S., & Shin, M. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6348 · Cited by 783
Research works printed but not linked: 4
- R.B. Banati, K. Beyreuter, Alzheimer’s disease, in: H. Kettenman, B.R. Ransom (Eds.), Neuroglia, Oxford University Press, New York, Oxford, 1995, pp. 1027–1043.
- K. Iqbal, Prevalence and neurobiology of Alzheimer disease: some highlights, in: K. Iqbal, D.R.C. McLachlan, B. Winblad, H.M. Wisniewski (Eds.), Alzheimer’s Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies, Wiley-Interscience Publication, Chichester, 1991, pp. 9–12.
- M. Rossor, Disorders of psychic function. Dementia, in: A.K. Asbury, G.M. McKhann, W.I. McDonald (Eds.), Disease of the Nervous System: Clinical Neurobiology, 2nd ed., W.B Saunders Company, Philadelphia, 1992, pp. 788–794.
- B.A. St Pierre, J.E. Merill, J.M. Dopp, Effects of cytokines on the CNS cells: glia, in: R.M. Ransohoff, E.N. Benveniste (Eds.), Cytokines and the CNS, CRC press, Boca Raton, Florida, 1996, pp. 151–168.
Cited by
Inflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Iosif, R. E., Ekdahl, C. T., Ahlenius, H., Pronk, C. J. H., Bonde, S., Kokaia, Z., Jacobsen, S.-E. W., & Lindvall, O. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2723-06.2006 · Cited by 463
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
Metadata
- Authors
- Tarkowski, E., Liljeroth, A.-M., Minthon, L., Tarkowski, A., Wallin, A., & Blennow, K.
- Affiliations
- University of Gothenburg (SE)
- Lund University (SE)
- Corresponding author
- Tarkowski, Elisabeth
- Venue
- Brain Research Bulletin
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 61
- Issue
- 3
- Pages
- 255-260
- ISSN
- 0361-9230 (ISSN-L)
- OpenAlex
- W2014473727
- Cited by
- 219
- References
- 50
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 12 · 2021: 10 · 2020: 14 · 2019: 13 · 2018: 12 · 2017: 6 · 2016: 12 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 13
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Brain Research Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, vascular dementia, dementia, inflammatory cytokines, anti-inflammatory cytokines, cerebrospinal fluid, TNF-α, IL-1β, interleukin-1 receptor antagonist, interleukin-6, lymphotoxin, genetic polymorphism, neuronal injury, apoptosis, neuroprotection, amyloidogenesis, white matter lesions
- MeSH terms
- Brain, Dementia, Humans, Interleukin-1, Polymorphism, Genetic, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Receptors, Interleukin-1, Receptors, Interleukin-1 Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. https://app.cochat.ai/papers/10.1016/s0361-9230(03)00088-1
- The paper
- Tarkowski, E., Liljeroth, A.-M., Minthon, L., Tarkowski, A., Wallin, A., & Blennow, K. (2003). Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Research Bulletin. https://doi.org/10.1016/s0361-9230(03)00088-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.